Marken Commissions New and Expanded London Operational Hub
Marken announced that it has completed all commissioning work for its new operational hub in Feltham, UK. The new location at 648 River Gardens in Feltham is within 4 miles (6 KM) of Heathrow Airport and part of the North Feltham Trading Estate Industrial Center.
The 18.5k sq ft facility is completely occupied by Marken operational personnel and will be one of the company’s flagship facilities joining an expanding network. The facility is equipped with space for product staging, re-icing, automatic scanning, quarantined goods, secure storage for dangerous goods, import and export operations and IT support. It will also have ample office space for the London branch operations which also has responsibility for all clients operating within the UK and Ireland.
“This new facility is in direct response to recent expansion requirements in the UK to support our growing client base”, said CEO, Wes Wheeler. “We have designed this facility to accommodate all of the needs of the life science industry including inbound shipments of clinical samples and outbound shipments of drug product, active pharmaceutical ingredients and patient kits. We have allowed ample room for growth and for expanded services. We are very excited to be upgrading our facilities in the UK.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
